Authors: Stevenson, JP Redlinger, M Kluijtmans, LAJ Sun, WJ Algazy, K Giantonio, B Haller, DG Hardy, C Whitehead, AS O'Dwyer, PJ

Citation: Jp. Stevenson et al., Phase I clinical and pharmacogenetic trial of irinotecan and raltitrexed administered every 21 days to patients with cancer, J CL ONCOL, 19(20), 2001, pp. 4081-4087

Authors: Goluboff, ET Prager, D Rukstalis, D Giantonio, B Madorsky, M Barken, I Weinstein, IB Partin, AW Olsson, CA

Citation: Et. Goluboff et al., Safety and efficacy of exisulind for treatment of recurrent prostate cancer after radical prostatectomy, J UROL, 166(3), 2001, pp. 882-886

Authors: Sun, WJ Stevenson, JP Gallagher, M Giantonio, B Algazy, K Haller, D Vaughn, D Raskay, BJ O'Dwyer, PJ

Citation: Wj. Sun et al., A phase I trial of topotecan and gemcitabine administered weekly for 3 consecutive weeks to patients with advanced tumors, CANCER, 92(2), 2001, pp. 414-419